lead position
Trademarks
From seller vetting and proprietary screening technology to brand collaboration and industry partnerships, Temu explains how its intellectual property enforcement programme combats infringement on its marketplace
August 10, 2026
Features list
-
Ben Brigou and Jaap Mannaerts of NLO examine the different incentives the EU offers in order to encourage pharmaceutical innovation, including SPCs, regulatory measures and the Bolar exemption
-
Cristina Biggi of Bugnion examines the introduction of the new SPC manufacturing waiver, including the process that led to its creation and the amendments it makes to the SPC regulation -
Magnus Johansson and Behdad Assadi of Valea examine the circumstances in which AI is patentable in Europe, analysing when AI makes a technical contribution to an invention and looking at two examples of AI
-
Max Walters delves into SPC referrals to the CJEU, asking lawyers why the topic is proving so controversial and why UK courts have taken it upon themselves to try to resolve issues
-
Youping Ma and Guoquan Yang of Bridgeon examine how AI can be protected by trade secrets, analysing which aspects of AI technologies should be safeguarded using this method
Local Insights
Sponsored by
Inspicos
Peter Koefoed of Inspicos examines how the EPO Enlarged Board of Appeal referral G 1/26 could clarify the application of G 1/24 when assessing the allowability of amended patent claims under the EPC
Sponsored by
Maiwald
Alexander Ortlieb, Moritz Kampmann, and Stephan Maidl of Maiwald highlight six EPO appeal decisions that map the absolute floor of what patent applications for AI inventions must disclose – and how spectacularly some applicants miss that mark
Sponsored by
Inventa
Vítor Palmela Fidalgo of Inventa reviews three years of Unified Patent Court jurisprudence, examining emerging approaches to claim interpretation, prosecution history, doctrine of equivalents, and prior use
Sponsored by
Bird & Bird
The singer is among an increasing number of celebrities using trademark law to counter AI-generated impersonation. Ann Henry, Sarah McMullen, and Isabel Humburg of Bird & Bird (Ireland) examine evolving challenges for brand owners
Sponsored by
Inspicos
Nils Byg Jørgensen of Inspicos says a recent EPO decision addresses the extent to which the description and drawings shall be consulted when interpreting claims under European Patent Convention provisions other than patentability
Sponsored by
Inspicos
Jakob Pade Frederiksen of Inspicos provides a status update on the pending case in the lead-up to oral proceedings before the EPO Enlarged Board of Appeal on May 8 2026
Sponsored by
Bird & Bird
Anna Wolters-Höhne of Bird & Bird summarises proposed updates regarding market access activities and explains the practical implications for patentees and potential defendants, with reference to recent Unified Patent Court case law
Sponsored by
NLO
Emily Flood and Gamze Gezer-Voerknecht of NLO examine how European patent law applies to the booming nutraceuticals market, focusing on EPO practice, therapeutic versus non‑therapeutic claims, and strategic drafting considerations
Sponsored by
Patrinos & Kilimiris
Maria Kilimiris of Patrinos & Kilimiris explains a recent decision regarding how genuine use is assessed for trademarks registered across broad categories of goods and their subcategories
Sponsored by
Bird & Bird
Annika Lückemann and Jan van Dieck of Bird & Bird analyse the Unified Patent Court’s opening ruling concerning a supplementary protection certificate, highlighting procedural peculiarities, urgency considerations, and possible implications for pharmaceutical originator-generic disputes